BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Oct 14, 2017

SEC Form 4/A — Form 4/A

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2015-03-03

Reporting Person: FUCHS HENRY J (President, Worldwide R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-03	Common Stock	J	0	—	Acquired	88515	Direct

Footnotes

F1: On March 5, 2015, the reporting person filed a Form 4 which inadvertently reported an incorrect total amount of securities beneficially owned following the reported transaction. This amendment corrects such total.